Lysophospholipase L2 of Vibrio cholerae O1 affects cholera toxin production

FEMS Immunology and Medical Microbiology

Volumn 15, Issue 1, 1996, Pages 9-15

  Whayeb, Shatha A ^a   Yamamoto, Koichiro ^a   Castillo, Melia Ellen Y ^a   Tojo, Hiromasa ^b   Honda, Takeshi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Cholera toxin; Lysophospholipase L2; Vibrio cholerae O1

Indexed keywords

CHOLERA TOXIN; LYSOPHOSPHOLIPASE;

ANIMAL TISSUE; ARTICLE; CHOLERA; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RABBIT; VIBRIO CHOLERAE; VIRULENCE; ANIMAL; BIOSYNTHESIS; ENZYMOLOGY; GENETIC COMPLEMENTATION; GENETICS; IMMUNOLOGY; MUTATION;

ANIMALS; CHOLERA TOXIN; GENETIC COMPLEMENTATION TEST; LYSOPHOSPHOLIPASE; MUTATION; RABBITS; VIBRIO CHOLERAE;

EID: 0030201174     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/0928-8244(96)00036-3     Document Type: Article

References (25)

1. [1] DiRita, V.J. (1992) Co-ordinate expression of virulence genes by ToxR in Vibrio cholerae. Mol. Microbiol. 6, 451-458.
2. [2] DiRita, V.J., Parsot, C., Jander, G. and Mekalanos, J.J. (1991) Regulatory cascade controls virulence in Vibrio cholerae. Proc. Natl. Acad. Sci. USA 88, 5403-5407.
3. [3] Michalski, J., Galen, J., Fasano, A. and Kaper, J.B. (1993) CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain. Infect. Immun. 61, 4462-4468.
4. [4] Tacket, C.O., Losonsky, G., Nataro, J.P., Cryz, S.J., Edelman, R., Fasano, A., Michalski, J., Kaper, J.B. and Levine, M.M. (1993) Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD103-HgR. J. Infect. Dis. 166, 837-841.
5. 2 of Vibrio cholerae O1. Biochim. Biophys. Acta 1300, 1-4.
6. [6] Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: a Laboratory Manual. Cold Spring Harbor Laboratory Press, New York.
7. [7] Finkelstein, R., Atthasampunna, P., Chulasamaya, M. and Charunmethee, P. (1966) Pathogenesis of experimental cholera: biologic activities of purified procholeragen A. J. Immun. 96, 440-449.
8. [8] Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A. and Struhl, K. (1987) Current Protocols in Molecular Biology. Wiley, New York.
9. [9] Miller, V.L. and Mekalanos, J.J. (1988) A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires ToxR. J. Bacteriol. 170, 2575-2583.
10. [10] Ming, X., Yamamoto, K. and Honda, T. (1994) Construction and characterization of an isogenic mutant of V. parahaemolyticus having a deletion in the thermostable direct hemolysin-related hemolysin gene (trh). J. Bacteriol. 176, 4757-4760.
11. 2 of E. coli K-12. J. Biochem. 98, 1117-1125.
12. [12] Redinbaugh, M.G. and Campell, W.H. (1985) Adaptation of the dye binding protein assay to microtiter plates. Anal. Biochem. 147, 144-147.
13. 2 isozymes. J. Lipid Res. 34, 837-844.
14. [14] Yamamoto, K., Ichinose, Y., Nakasone, N., Tanabe, M., Nagahama, M., Sakurai, J. and Iwanaga, M. (1986) Identity of hemolysis produced by Vibrio cholerae Non-O1 and V. cholerae O1, Biotype El Tor. Infect. Immun. 51, 927-931.
15. [15] Ichinose, Y., Yamamoto, K., Nakasone, N., Tanabe, M., Takeda, T., Miwatani, T. and Iwanaga, M. (1987) Enterotoxicity of El Tor-Like hemolysin of Non-O1 Vibrio cholerae. Infect. Immun. 55, 1090-1093.
16. [16] Iwanaga, M. and Kuyyakanond, T. (1987) Large production of cholera toxin by Vibrio cholerae O1 in yeast extract peptone water. J. Clin. Microbiol. 25, 2314-2316
17. [17] De, S.N. and Chatterjee, D.N. (1953) An experimental study of the mechanism of action of V. cholerae on the intestinal mucous membrane. J. Pathol. Bacteriol. 66, 559-562.
18. [18] Berg, D.E., Weiss, A. and Crossland, L. (1980) Polarity of Tn5 insertion mutations in Escherichia coli. J. Bacteriol. 142, 439-446.
19. [19] Masuda, N., Kitamura, N. and Saito, K. (1991) Primary structure of protein moiety of Penicillium notatum phospholipase B deduced from the cDNA. FEBS 202, 783-787.
20. [20] Garsetti, D., Steiner, M., Holtsberg, F., Ozgur, L., Egan, R. and Clark, M. (1993) Comparison of six mammalian lysophospholipases. J. Lipid Mediat. 6, 223-232.
21. [21] Martin, T.W. and Lagunoff, D. (1979) Interaction of lysophospholipid and mast cells. Nature 279, 250-252.
22. [22] Ratez, C.R.H. (1978) Enzymology, genetics, and regulation of membrane phospholipid synthesis in E. coli. Microbiol. Rev. 42, 614-659.
23. [23] Weltzien, H.U. (1979) Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. Biochim. Biophys. Acta. 559, 259-287.
24. [24] Oishi, K., Raynor, R.L., Charp, P.A. and Kuo, J.F. (1988) Regulation of protein kinase C by lysophospholipids (potential role in signal transduction). J. Biol. Chem. 263, 6865-6871.
25. [25] Van Rensburg, C.E.J, Joone, G.K., O'Sullivan, J.F. and Anderson, R. (1992) Antimicrobial activities of clofazimine and B669 are mediated by lysophospholipids. Antimicrob. Agents Chemother. 36, 2729-2735.